Abstract:The optimal treatment for hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) remains controversial. We aimed to investigate the best treatment for patients with HCC with PVTT.From January 2002 to January 2014, the data from all consecutive patients with HCC with PVTT who underwent surgical treatment (ST), TACE, TACE combined with sorafenib (TACE-Sor), or TACE combined with radiotherapy (TACE-RT) in the 4 largest tertiary hospitals in China were analyzed retrospectively. The patients were divided into 3 subtypes according to the extent of PVTT in the portal vein (type I-III). The primary endpoint was overall survival (OS).A total of 1580 patients with HCC with PVTT were included in the study. The median survival times (MST) for ST (n = 745) for type I, II, and III patients (95% CI) were 15.9 (13.3-18.5), 12.5 (10.7-14.3), and 6.0 (4.3-7.7) months, respectively. The corresponding figures for patients after TACE (n = 604) were 9.3 (5.6-12.9), 4.9 (4.1-5.7), and 4.0 (3.1-4.9), respectively; for patients after TACE-Sor (n = 113) 12.0 (6.6-17.4), 8.9 (6.7-11.1), and 7.0 (3.0-10.9), respectively; and for patients after TACE-RT (n = 118) 12.2 (0-24.7), 10.6 (6.8-14.5), and 8.9 (5.2-12.6), respectively. Comparison among the different treatments for the 3 subtypes of PVTT patients after propensity score (PS) matching showed the effectiveness of ST to be the best for type I and type II PVTT patients, and TACE-RT was most beneficial for type III patients. Treatment was an independent risk factor of OS.ST was the best treatment for type I and II PVTT patients with Child-Pugh A and selected B liver function. TACE-RT should be given to type III PVTT patients.

Advances in the Treatment of Hepatocellular Carcinoma Combined with Hepatic Vein Tumor Thrombus

The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

[Progress in Surgical Treatment of Hepatocellular Carcinoma with Tumor Thrombus in the Inferior Vena Cava].

Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy

Advances in Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

Recent Advances on the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)

Bottleneck and strategies in the treatment of hepatocellular carcinoma with portal vein tumor thrombus

Recent advances in the combined use of radiation therapy and multimodality therapies for hepatocellular carcinoma with portal vein tumor thrombus

Recent advances in treatment strategies for hepatocellular carcinoma with portal vein cancer thrombus

Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition).

Multidisciplinary Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus - Eastern Hepatobiliary Surgical Hospital Consensus Statement.

Multimodality Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

Portal Vein Tumor Thrombus is a Bottleneck in the Treatment of Hepatocellular Carcinoma

The Progress in Diagnosis and Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

The Role of Interventional Treatment on Hepatocellular Carcinoma Combined with Portal Vein Tumor Thrombosis

Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review

New advances in the treatment of intermediate and advanced hepatocellular carcinoma

Multimodality Treatment in Hepatocellular Carcinoma Patients with Tumor Thrombi in Portal Vein

Research progress on the formation mechanism of hepatocellular carcinoma with portal vein tumor thrombus